Search research articles
Contact Us
Filters
Showing results (141-150 of 303) with videos related to
Page
of 31
Sort By:
Biomedizinische Technik. Biomedical Engineering
|
September 18, 2013
Finite Element Study of the Accommodation Behaviour of The Crystalline Lens after fs-Laser Treatment
S Besdo, J Wiegand, J Hahn, et al.
Health Physics
|
April 5, 2000
Radon and thoron in cave dwellings (Yan'an, China)
J Wiegand, S Feige, X Quingling, et al.
Endocrinology
|
June 21, 2001
Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40))
C Wulff, S J Wiegand, P T Saunders, et al.
Experimental Neurology
|
November 1, 1993
The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease
R M Lindsay, C A Altar, J M Cedarbaum, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 9, 1996
Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease
K D Anderson, N Panayotatos, T L Corcoran, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
October 12, 2012
The Toxicology Investigators Consortium Case Registry--the 2011 experience
Timothy J Wiegand, Paul M Wax, Tayler Schwartz, et al.
Pharmacology, Biochemistry, and Behavior
|
November 5, 1999
Peptide immunoreactivity in aged rat cortex and hippocampus as a function of memory and BDNF infusion
S D Croll, C R Chesnutt, N A Greene, et al.
Clinical Nephrology
|
June 19, 2010
Resistance management in chronic hepatitis B complicated by renal failure
J Wiegand, T Karlas, I Schiefke, et al.
Clinical Nephrology
|
March 25, 2005
Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?
A Potthoff, J Wiegand, J B Lüth, et al.
Zeitschrift Fur Gastroenterologie
|
January 15, 2010
[ALT screening for chronic liver diseases: scrutinizing the evidence]
H Wedemeyer, W P Hofmann, S Lueth, et al.
Page
of 31
Search research articles
Search
Showing results (141-150 of 303) with videos related to
Sort By:
Page
of 31
Biomedizinische Technik. Biomedical Engineering
|
September 18, 2013
Finite Element Study of the Accommodation Behaviour of The Crystalline Lens after fs-Laser Treatment
S Besdo, J Wiegand, J Hahn, et al.
Health Physics
|
April 5, 2000
Radon and thoron in cave dwellings (Yan'an, China)
J Wiegand, S Feige, X Quingling, et al.
Endocrinology
|
June 21, 2001
Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40))
C Wulff, S J Wiegand, P T Saunders, et al.
Experimental Neurology
|
November 1, 1993
The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease
R M Lindsay, C A Altar, J M Cedarbaum, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 9, 1996
Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease
K D Anderson, N Panayotatos, T L Corcoran, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
October 12, 2012
The Toxicology Investigators Consortium Case Registry--the 2011 experience
Timothy J Wiegand, Paul M Wax, Tayler Schwartz, et al.
Pharmacology, Biochemistry, and Behavior
|
November 5, 1999
Peptide immunoreactivity in aged rat cortex and hippocampus as a function of memory and BDNF infusion
S D Croll, C R Chesnutt, N A Greene, et al.
Clinical Nephrology
|
June 19, 2010
Resistance management in chronic hepatitis B complicated by renal failure
J Wiegand, T Karlas, I Schiefke, et al.
Clinical Nephrology
|
March 25, 2005
Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?
A Potthoff, J Wiegand, J B Lüth, et al.
Zeitschrift Fur Gastroenterologie
|
January 15, 2010
[ALT screening for chronic liver diseases: scrutinizing the evidence]
H Wedemeyer, W P Hofmann, S Lueth, et al.
Page
of 31